Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols.

A novel quantitative luminometric immunoassay (LIA) has been developed for the measurement of wild-type and mutant p53 protein in extracts from breast tumour tissue. The LIA was found to yield reliable estimates of p53 expression in cytosol samples routinely prepared for steroid receptor analysis as...

Descripción completa

Detalles Bibliográficos
Autores principales: Borg, A., Lennerstrand, J., Stenmark-Askmalm, M., Fernö, M., Brisfors, A., Ohrvik, A., Stål, O., Killander, D., Lane, D., Brundell, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033772/
https://www.ncbi.nlm.nih.gov/pubmed/7734292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033772/
https://www.ncbi.nlm.nih.gov/pubmed/7734292

Ejemplares similares